LONG-TERM EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY BASELINE BODY MASS INDEX

被引：2
|
作者：
Chupp, Geoffrey L.
Lugogo, Njira L.
Wechsler, Michael E.
Lawson, Kaitlyn
Lindsley, Andrew
Spahn, Joe D.
Ambrose, Christopher
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.075
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：9A / 14A
页数：6
相关论文
共 50 条
  • [1] Long-term safety and efficacy of tezepelumab in adolescents with severe, uncontrolled asthma
    Brusselle, Guy
    Cook, Bill
    Lawson, Kaitlyn
    Ponnarambil, Sandhia
    Lindsley, Andrew
    Stolz, Daiana
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [2] DESTINATION: TEZEPELUMAB LONG-TERM SAFETY AND EFFICACY VERSUS PLACEBO IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA
    Menzies-Gow, A.
    Wechsler, M. E.
    Brightling, C. E.
    Korn, S.
    Bednarczyk, A.
    Ponnarambil, S.
    Almqvist, G.
    Lawson, K.
    Caveney, S.
    Bowen, K.
    Colice, G.
    THORAX, 2022, 77 : A32 - A32
  • [3] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA GROUPED BY BASELINE BMI IN THE NAVIGATOR STUDY
    Chupp, Geoffrey
    Menzies-Gow, Andrew
    Ambrose, Christopher
    Cook, William
    Kmita, Kamil
    Lindsley, Andrew
    Llanos-Ackert, Jean-Pierre
    Colice, Gene
    Lugogo, Njira
    CHEST, 2021, 160 (04) : 37A - 40A
  • [4] EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA AND HIGH BASELINE BLOOD EOSINOPHIL COUNTS
    Jain, N.
    Llanos-Ackert, J.
    Ambrose, C.
    Cook, B.
    Ponnarambil, S.
    Martin, N.
    Webb, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S36 - S37
  • [5] Efficacy of Tezepelumab in Patients With Severe, Uncontrolled Asthma and Fungal Sensitization
    Corren, Jonathan
    Mathur, Sameer K.
    Carr, Tara F.
    Wardlaw, Andrew J.
    Caminati, Marco
    Martin, Nicole
    Ponnarambil, Sandhia
    Lindsley, Andrew W.
    Spahn, Joseph D.
    Martin, Neil
    Geffen, David
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB97 - AB97
  • [6] Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma and Perennial Allergy
    Corren, Jonathan
    Ambrose, Christopher S.
    Salapa, Kinga
    Roseti, Stephanie L.
    Griffiths, Janet M.
    Parnes, Jane R.
    Colice, Gene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (12): : 4334 - +
  • [7] EFFICACY OF TEZEPELUMAB IN HISPANIC OR LATINO PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA
    Hill, J.
    Carr, T.
    Ambrose, C.
    Martin, N.
    Ponnarambil, S.
    Lindsley, A.
    Martin, N.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S35 - S35
  • [8] Efficacy of tezepelumab in adolescents with severe, uncontrolled asthma
    Israel, Elliot
    Menzies-Gow, Andrew
    Chupp, Geoffrey
    Ambrose, Chris
    Cook, Bill
    Hunter, Gillian
    Llanos-Ackert, Jean-Pierre
    Downie, John
    Colice, Gene
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [9] Dupilimab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Asthma by Body Mass Index
    Korn, Stephanie
    Busse, William W.
    Maria Echave-Sustaeta, Jose
    Dixon, Anne E.
    Mucsi, Janos
    Rice, Megan S.
    Deniz, Yamo
    Rowe, Paul
    Staudinger, Heribert W.
    Amin, Nikhil
    Ruddy, Marcella
    Graham, Neil M. H.
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [10] EFFECT OF TEZEPELUMAB ON EXACERBATIONS IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA, ACCORDING TO BASELINE BODY MASS INDEX: RESULTS FROM THE PHASE 2B PATHWAY STUDY
    Ambrose, C. S.
    Colice, G.
    Salapa, K.
    Parnes, J. R.
    Corren, J.
    THORAX, 2021, 76 : A83 - A83
12345